{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:57:15Z","timestamp":1790096235092,"version":"4.0.1"},"reference-count":31,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:p>\n            LYS228 is a novel monobactam with potent activity against\n            <jats:named-content content-type=\"genus-species\">Enterobacteriaceae<\/jats:named-content>\n            . LYS228 is stable to metallo-\u03b2-lactamases (MBLs) and serine carbapenemases, including\n            <jats:named-content content-type=\"genus-species\">Klebsiella pneumoniae<\/jats:named-content>\n            carbapenemases (KPCs), resulting in potency against the majority of extended-spectrum \u03b2-lactamase (ESBL)-producing and carbapenem-resistant\n            <jats:named-content content-type=\"genus-species\">Enterobacteriaceae<\/jats:named-content>\n            strains tested.\n          <\/jats:p>","DOI":"10.1128\/aac.00552-18","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T17:48:58Z","timestamp":1537552138000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":34,"title":["<i>In Vitro<\/i>\n            Activity of LYS228, a Novel Monobactam Antibiotic, against Multidrug-Resistant Enterobacteriaceae"],"prefix":"10.1128","volume":"62","author":[{"given":"Johanne","family":"Blais","sequence":"first","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Emeryville, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lopez","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Emeryville, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Li","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Emeryville, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Ruzin","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Emeryville, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srijan","family":"Ranjitkar","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Emeryville, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9858-9818","authenticated-orcid":false,"given":"Charles R.","family":"Dean","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Emeryville, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Leeds","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Emeryville, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Casarez","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Emeryville, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Simmons","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Emeryville, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folkert","family":"Reck","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Emeryville, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/595011"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2010.09.006"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00912-17"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01291-15"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2014.06.010"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2009.140344"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70059-7"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03938-14"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw090"},{"key":"e_1_3_2_11_2","volume-title":"Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics","author":"Tacconelli E","year":"2017","unstructured":"Tacconelli E, Magrini N. 2017. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir611"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12091"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00424-7"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.01.023"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2007.121004"},{"key":"e_1_3_2_17_2","first-page":"165","article-title":"Vital signs: carbapenem-resistant Enterobacteriaceae","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","unstructured":"Centers for Disease Control and Prevention. 2013. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 62:165\u2013170.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc6820"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp255"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2018.01.006"},{"key":"e_1_3_2_21_2","volume-title":"In vitro activity of LYS228 against Enterobacteriaceae, including molecularly characterized multidrug-resistant isolates, abstr Saturday-293","author":"Mendes R","year":"2017","unstructured":"Mendes R, Rhomberg PR, Schaefer B, Huband MD, Flamm RK. 2017. In vitro activity of LYS228 against Enterobacteriaceae, including molecularly characterized multidrug-resistant isolates, abstr Saturday-293. Abstr 2017 Am Soc Microbiol Microbe Meet, New Orleans, LA."},{"key":"e_1_3_2_22_2","volume-title":"CLSI document M100","author":"Clinical and Laboratory Standards Institute","year":"2018","unstructured":"Clinical and Laboratory Standards Institute. 2018. Performance standards for antimicrobial susceptibility testing\u201428th ed. CLSI document M100. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"28"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku568"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01525-09"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.2.219"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.27.5.821"},{"key":"e_1_3_2_27_2","volume-title":"In vivo efficacy of the novel monobactam LYS228 in a neutropenic murine thigh model of infection with carbapenem-resistant Enterobacteriaceae, abstr Saturday-291","author":"Growcott EJ","year":"2017","unstructured":"Growcott EJ, Cariagat T, Gold J, Camboa L, Lopez S, Simmons RL, Osborne CS. 2017. In vivo efficacy of the novel monobactam LYS228 in a neutropenic murine thigh model of infection with carbapenem-resistant Enterobacteriaceae, abstr Saturday-291. Abstr 2017 Am Soc Microbiol Microbe Meet, New Orleans, LA."},{"key":"e_1_3_2_28_2","volume-title":"Pharmacokinetics and pharmacodynamics of the novel monobactam LYS228 in the neutropenic murine thigh infection model, abstr Saturday-289","author":"Growcott EJ","year":"2017","unstructured":"Growcott EJ, Zang X, Cariaga TA, Lopez S, Simmons RL, Osborne CS. 2017. Pharmacokinetics and pharmacodynamics of the novel monobactam LYS228 in the neutropenic murine thigh infection model, abstr Saturday-289. Abstr 2017 Am Soc Microbiol Microbe Meet, New Orleans, LA."},{"key":"e_1_3_2_29_2","volume-title":"CLSI document M07-A10","author":"Clinical and Laboratory Standards Institute","year":"2015","unstructured":"Clinical and Laboratory Standards Institute. 2015. Methods for dilution susceptibility tests for bacteria that grow aerobically; approved standard\u201410th ed. CLSI document M07-A10. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"10"},{"key":"e_1_3_2_30_2","volume-title":"CLSI document M26-A","author":"Clinical and Laboratory Standards Institute","year":"2009","unstructured":"Clinical and Laboratory Standards Institute. 2009. Methods for determining bactericidal activity of antimicrobial agents; approved guideline. CLSI document M26-A. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_2_31_2","volume-title":"Avycaz: highlights of prescribing information","author":"Actavis, Inc","year":"2015","unstructured":"Actavis, Inc. 2015. Avycaz: highlights of prescribing information. Actavis, Inc., Parsippany, NJ. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/206494s000lbl.pdf."},{"key":"e_1_3_2_32_2","volume-title":"Tygacil: highlights of prescribing information","author":"Wyeth Pharmaceuticals, Inc","year":"2016","unstructured":"Wyeth Pharmaceuticals, Inc. 2016. Tygacil: highlights of prescribing information. Wyeth Pharmaceuticals, Inc., Philadelphia, PA. http:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=491."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00552-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00552-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T20:55:14Z","timestamp":1645476914000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00552-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1128\/AAC.00552-18"],"URL":"https:\/\/doi.org\/10.1128\/aac.00552-18","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"2018-03-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00552-18"}}